March 8 (Reuters) - Combigene AB COMBI.ST :
* THE BOARD OF DIRECTORS OF COMBIGENE RESOLVES ON A FULLY
GUARANTEED RIGHTS ISSUE OF APPROXIMATELY SEK 75 MILLION
* RIGHTS ISSUE WILL, IF FULLY SUBSCRIBED, PROVIDE COMPANY
WITH
APPROXIMATELY SEK 75 MILLION BEFORE ISSUE COSTS
* NET PROCEEDS WILL, AMONG OTHERS, BE USED TO FINANCE FINAL
PARTS
OF COMBIGENE'S PRECLINICAL PROGRAM FOR CG01 AND INITIATED IN
VIVO STUDIES IN LIPODYSTROPHY PROJECT CGT2
* SUBSCRIPTION PERIOD: 17 MARCH 2021 UP TO AND INCLUDING 31
MARCH
2021.
* SUBSCRIPTION PRICE: SEK 0.45 PER EACH SHARE.
Source text for Eikon: ID:nMFN2fKqWP
Further company coverage: COMBI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))